UCLA School of Medicine ( Site 4006) — Los Angeles, California

UCLA School of Medicine ( Site 4006) is a clinical research site located in Los Angeles, California, United States 90095-1670.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA School of Medicine ( Site 4006) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease.

Sponsors: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA School of Medicine ( Site 4006)?

UCLA School of Medicine ( Site 4006) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA School of Medicine ( Site 4006) conducted?

UCLA School of Medicine ( Site 4006) has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease.

Is UCLA School of Medicine ( Site 4006) accredited by Crixeo Health?

UCLA School of Medicine ( Site 4006) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA School of Medicine ( Site 4006)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.